Article info

Download PDFPDF

Original article
The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW

Authors

  1. Correspondence to Irene van der Horst-Bruinsma; IE.vanderHorst{at}amsterdamumc.nl
View Full Text

Citation

van der Horst-Bruinsma I, van Bentum R, Verbraak FD, et al
The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW

Publication history

  • Received December 13, 2019
  • Revision received February 10, 2020
  • Accepted March 20, 2020
  • First published May 5, 2020.
Online issue publication 
May 05, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.